3
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future: Retraction

      retraction
      Infectious Microbes & Diseases
      Lippincott Williams & Wilkins

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          At the request of the authors, the Editors and Publisher retract the article “Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future” by Alsabony et al. 1 published post-acceptance on January 20, 2021 in Infectious Microbes & Diseases. The content and structure of this article display high similarity with another article that is currently under review for consideration of publication in another journal. The authors, the Editors and Publisher all agree that this article is not suitable to be published.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: not found
          • Book: not found

          Use of antimicrobial peptides against SARS-CoV-2: today is the future: Retraction

            Bookmark

            Author and article information

            Journal
            IM9
            Infectious Microbes & Diseases
            Lippincott Williams & Wilkins (Hagerstown, MD )
            2641-5917
            March 2021
            25 March 2020
            : 3
            : 1
            : 49
            Article
            IMD-21-004 00008
            10.1097/IM9.0000000000000056
            8011342
            c589e8fa-91b0-4146-bb35-9003c51841ef
            Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

            This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

            This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

            History
            Categories
            Retraction
            Custom metadata
            TRUE

            Comments

            Comment on this article